Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001231919-26-000300

Director bought 369,000 shares at an average $23.75 ($8,762,797)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2026-03-27 Purchase +310,700 $23.67 $7,354,269 5,767,221 I: show line 1 in the form
RA CAPITAL MANAGEMENT, L.P. Director 2026-03-30 Purchase +58,300 $24.16 $1,408,528 5,825,521 I: show line 2 in the form
Open-market purchases · 369,000 sh · avg $23.75 · $8,762,797
Loading xslF345X06/form4-03312026_040301.xml…